FDA Backs Pfizer Covid Shot for Kids

The transcript discusses the process of authorizing COVID-19 vaccines for children aged 5 to 11 in the U.S., highlighting the steps involving the CDC and FDA. It explores the potential impact on families and the economy, as more children could be vaccinated, allowing families to engage more fully in economic activities. Concerns about a possible winter COVID-19 wave are addressed, with hopes that increased vaccination rates will mitigate this risk. The final steps in the authorization process are outlined, with expectations that the CDC will approve the vaccine following the FDA's recommendation.

What steps are involved in the vaccination campaign as described in the text?

What was the outcome of the FDA advisory committee's vote regarding the vaccine?